TY - JOUR AB - The present study aimed to explore the diagnostic and prognostic value of lncRNA maternally expressed 3 (MEG3) in cervical cancer. Eighty‑four patients with cervical cancer from February 2013 to March 2014 were enrolled in the observation group (OG), and another 58 female subjects who underwent physical examination at Huangshi Central Hospital were enrolled as the control group (CG). The serum MEG3 expression of patients in the two groups was detected by RT‑qPCR, and the ability of MEG3 to aid in the diagnosis of cervical cancer, lymph node metastasis and FIGO staging, as well as to predict mortality was evaluated by ROC curve. In addition, the patients in the OG were divided into high‑ and low‑expression groups according to the median value of MEG3. Kaplan Meier was employed to analyze the survival status, and Cox regression to analyze the independent prognostic factors of cervical cancer patients. The results of the present study revealed that the serum MEG3 expression in the OG was significantly lower than that of the CG (P<0.05). The area under the curve (AUC) of MEG3 in diagnosing cervical cancer was 0.844, the AUC in predicting mortality was 0.858, while that in diagnosing lymph node transfer was 0.707, and that in diagnosing FIGO staging was 0.791. The 5‑year survival rate of the high‑expression group was higher than that of the low‑expression group (P=0.020). Multivariate analysis indicated that MEG3 (HR, 0.173; 95 CI%, 0.028‑0.919), lymph node metastasis (HR, 2.259; 95 CI%, 1.004‑5.025) and FIGO staging (HR, 0.008; 95 CI%, 1.453‑6.248) were independent prognostic factors for cervical cancer patients. Collectively, lncRNA MEG3 may be a diagnostic marker and prognostic indicator for cervical cancer, and has a certain diagnostic value for lymph node metastasis and FIGO staging. Lymph node metastasis, FIGO stage III and IV, and low MEG3 levels were revealed to be independent prognostic factors for cervical cancer patients. AD - Department of Obstetrics and Gynecology, Huangshi Central Hospital, Huangshi, Hubei 435000, P.R. China Department of Gynecology, Huangshi Maternity and Children's Health Hospital, Huangshi, Hubei 435000, P.R. China AU - Wan,Shuqiong AU - Zhao,Huanqiu DA - 2020/11/01 DO - 10.3892/ol.2020.12044 IS - 5 JO - Oncol Lett KW - lncRNA MEG3 cervical cancer diagnosis prognosis PY - 2020 SN - 1792-1074 1792-1082 SP - 183 ST - Analysis of diagnostic and prognostic value of lncRNA MEG3 in cervical cancer T2 - Oncology Letters TI - Analysis of diagnostic and prognostic value of lncRNA MEG3 in cervical cancer UR - https://doi.org/10.3892/ol.2020.12044 VL - 20 ER -